Journal of the ASEAN Federation of Endocrine Societies最新文献

筛选
英文 中文
Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults With Type 2 Diabetes in the Philippines: Results from a Prospective, Non-interventional, Real-World Study.
IF 0.6
Journal of the ASEAN Federation of Endocrine Societies Pub Date : 2024-01-01 Epub Date: 2024-08-05 DOI: 10.15605/jafes.039.02.02
Nemencio Nicodemus, Nerissa Ang-Golangco, Grace Aquitania, Gregory Joseph Ryan Ardeña, Oliver Allan Dampil, Richard Elwyn Fernando, Nicole-Therese Flor, Sjoberg Kho, Roberto Mirasol, Araceli Panelo, Francis Pasaporte, Mercerose Puno-Rocamora, Ahsan Shoeb, Marsha Tolentino
{"title":"Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults With Type 2 Diabetes in the Philippines: Results from a Prospective, Non-interventional, Real-World Study.","authors":"Nemencio Nicodemus, Nerissa Ang-Golangco, Grace Aquitania, Gregory Joseph Ryan Ardeña, Oliver Allan Dampil, Richard Elwyn Fernando, Nicole-Therese Flor, Sjoberg Kho, Roberto Mirasol, Araceli Panelo, Francis Pasaporte, Mercerose Puno-Rocamora, Ahsan Shoeb, Marsha Tolentino","doi":"10.15605/jafes.039.02.02","DOIUrl":"10.15605/jafes.039.02.02","url":null,"abstract":"<p><strong>Objective: </strong>Blood glucose levels of the majority of Filipino patients with type 2 diabetes (T2D) remain uncontrolled. Insulin degludec/insulin aspart (IDegAsp) is a fixed-ratio co-formulation of the long-acting basal insulin degludec and the rapidacting prandial insulin aspart. The real-world ARISE (A Ryzodeg<sup>®</sup> Initiation and Switch Effectiveness) study investigated clinical outcomes across six countries in people with T2D who initiated IDegAsp. This publication presents the clinical outcomes of the Filipino cohort from a subgroup analysis of the ARISE study.</p><p><strong>Methodology: </strong>This 26-week, open-label, non-interventional study examined outcomes in adults with T2D initiating or switching to IDegAsp (N=185) from other antidiabetic treatments per local clinical guidance.</p><p><strong>Results: </strong>Compared with the baseline, there was a significant improvement in glycated hemoglobin at the end of the study (EOS) (estimated difference [ED] -1.4% [95% confidence interval -1.7, -1.1]; <i>P</i> <0.0001). Fasting plasma glucose (ED -46.1 mg/dL [-58.2, -34.0]; <i>P</i> <0.0001) and body weight (ED -1.0 kg [-2.0, -0.1]; <i>P</i> = 0.028) were significantly reduced at EOS compared with baseline. IDegAsp was associated with a decrease in the incidence of self-reported healthcare resource utilization. Adverse events were reported in eight (4.3%) participants.</p><p><strong>Conclusion: </strong>Initiating or switching to IDegAsp was associated with improved glycemic control, lower body weight, and lower HRU for people with T2D in the Philippines. No new, unexpected AEs were reported.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 2","pages":"61-69"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604473/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deceptive Brown Adipose Tissue. 欺骗性棕色脂肪组织
IF 0.6
Journal of the ASEAN Federation of Endocrine Societies Pub Date : 2024-01-01 Epub Date: 2024-05-12 DOI: 10.15605/jafes.039.01.21
Biswajit Payra, Abhranil Dhar, Pankaj Singhania, Akshay Khatri, Pranab Kumar Sahana
{"title":"Deceptive Brown Adipose Tissue.","authors":"Biswajit Payra, Abhranil Dhar, Pankaj Singhania, Akshay Khatri, Pranab Kumar Sahana","doi":"10.15605/jafes.039.01.21","DOIUrl":"10.15605/jafes.039.01.21","url":null,"abstract":"","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 1","pages":"131-132"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Focal Form of Diazoxide-resistant Congenital Hyperinsulinism with Good Response to Long-acting Somatostatin.
IF 0.6
Journal of the ASEAN Federation of Endocrine Societies Pub Date : 2024-01-01 Epub Date: 2024-07-31 DOI: 10.15605/jafes.039.02.03
Suhaimi Hussain, Nurshafinaz Salmah Mohd Fezal, Sarah Flanagan
{"title":"A Focal Form of Diazoxide-resistant Congenital Hyperinsulinism with Good Response to Long-acting Somatostatin.","authors":"Suhaimi Hussain, Nurshafinaz Salmah Mohd Fezal, Sarah Flanagan","doi":"10.15605/jafes.039.02.03","DOIUrl":"10.15605/jafes.039.02.03","url":null,"abstract":"<p><p>A four-year-old female who was born term via spontaneous vaginal delivery (SVD) with a birth weight of 3.4 kg had an onset of persistent hypoglycaemia at the 6<sup>th</sup> hour of life. She was diagnosed with congenital hyperinsulinism based on high glucose load, negative ketone and a good response to glucagon. Genetic workup revealed the presence of ATP Binding Cassette Subfamily C Member 8 (ABCC8 genes) mutation which indicated a focal form of congenital hyperinsulinism. She was resistant to the standard dose of oral diazoxide but responded to subcutaneous somatostatin. At the age of 3 years and 6 months, multiple daily injections of somatostatin were replaced with a long-acting monthly somatostatin analogue. With the present treatment, she had better glycaemic control, normal growth and was able to stop tube feeding.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 2","pages":"108-111"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aggressive Synchronous Papillary and Likely Follicular Thyroid Carcinomas in a Patient with Graves' Disease.
IF 0.6
Journal of the ASEAN Federation of Endocrine Societies Pub Date : 2024-01-01 Epub Date: 2024-08-01 DOI: 10.15605/jafes.039.02.08
Gerald Sng Gui Ren, Sarah Tan Ying Tse, Edwin Chew Jun Chen, Sangeeta Mantoo, Chng Chiaw Ling
{"title":"Aggressive Synchronous Papillary and Likely Follicular Thyroid Carcinomas in a Patient with Graves' Disease.","authors":"Gerald Sng Gui Ren, Sarah Tan Ying Tse, Edwin Chew Jun Chen, Sangeeta Mantoo, Chng Chiaw Ling","doi":"10.15605/jafes.039.02.08","DOIUrl":"https://doi.org/10.15605/jafes.039.02.08","url":null,"abstract":"<p><p>We report a case of an uncommonly aggressive presentation of the rare entity of synchronous papillary (PTC) and follicular thyroid carcinomas (FTC) in a 67-year-old female initially presenting with thyrotoxicosis from Graves' disease. She was found to have two thyroid nodules with extensive intra-cardiac tumour thrombus, symptomatic left pelvis bony metastasis with pathological fracture, pulmonary metastases and mediastinal lymph node metastases. Further investigations suggested a diagnosis of synchronous papillary and metastatic follicular thyroid cancer. Treatment with radical surgery followed by adjuvant therapeutic radioiodine ablation was proposed, but the patient declined all forms of cancer-specific therapy and was elected solely for a palliative approach to treatment. We discuss the diagnostic considerations in arriving at the diagnosis of synchronous thyroid malignancy - in this case the clear features of PTC and the strong probability of FTC due to invasiveness and metastatic follicular lesions. This case underscores potential limitations of the ACR TI-RADS system, notably with certain ultrasonographic features suggesting malignancy that might not be adequately captured. Notably, the aggressive presentation of DTC in this case may be contributed by the concurrent presence of Graves' Disease, suggesting heightened vigilance when assessing potential thyroid malignancies in such patients.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 2","pages":"119-123"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Before Low Serum Cortisol Can Be Attributed to SARS-CoV-2 Infection, Alternative Causes Must Be Ruled Out.
IF 0.6
Journal of the ASEAN Federation of Endocrine Societies Pub Date : 2024-01-01 Epub Date: 2024-07-30 DOI: 10.15605/jafes.039.02.06
Josef Finsterer, ArunSundar MohanaSundaram, Sounira Mehri
{"title":"Before Low Serum Cortisol Can Be Attributed to SARS-CoV-2 Infection, Alternative Causes Must Be Ruled Out.","authors":"Josef Finsterer, ArunSundar MohanaSundaram, Sounira Mehri","doi":"10.15605/jafes.039.02.06","DOIUrl":"https://doi.org/10.15605/jafes.039.02.06","url":null,"abstract":"","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 2","pages":"124-125"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604355/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Glutamate-Serine-Glycine Index as a Biomarker to Monitor the Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease.
IF 0.6
Journal of the ASEAN Federation of Endocrine Societies Pub Date : 2024-01-01 Epub Date: 2024-09-13 DOI: 10.15605/jafes.039.02.20
Nichole Yue Ting Tan, Elizabeth Shumbayawonda, Lionel Tim-Ee Cheng, Albert Su Chong Low, Chin Hong Lim, Alvin Kim Hock Eng, Weng Hoong Chan, Phong Ching Lee, Mei Fang Tay, Jason Pik Eu Chang, Yong Mong Bee, George Boon Bee Goh, Jianhong Ching, Kee Voon Chua, Sharon Hong Yu Han, Jean-Paul Kovalik, Hong Chang Tan
{"title":"The Glutamate-Serine-Glycine Index as a Biomarker to Monitor the Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease.","authors":"Nichole Yue Ting Tan, Elizabeth Shumbayawonda, Lionel Tim-Ee Cheng, Albert Su Chong Low, Chin Hong Lim, Alvin Kim Hock Eng, Weng Hoong Chan, Phong Ching Lee, Mei Fang Tay, Jason Pik Eu Chang, Yong Mong Bee, George Boon Bee Goh, Jianhong Ching, Kee Voon Chua, Sharon Hong Yu Han, Jean-Paul Kovalik, Hong Chang Tan","doi":"10.15605/jafes.039.02.20","DOIUrl":"https://doi.org/10.15605/jafes.039.02.20","url":null,"abstract":"<p><strong>Objective: </strong>Bariatric surgery effectively treats non-alcoholic fatty liver disease (NAFLD). The glutamate-serine-glycine (GSG) index has emerged as a non-invasive diagnostic marker for NAFLD, but its ability to monitor treatment response remains unclear. This study investigates the GSG index's ability to monitor NAFLD's response to bariatric surgery.</p><p><strong>Methodology: </strong>Ten NAFLD participants were studied at baseline and 6 months post-bariatric surgery. Blood samples were collected for serum biomarkers and metabolomic profiling. Hepatic steatosis [proton density fat fraction (PDFF)] and fibroinflammation (cT1) were quantified with multiparametric magnetic resonance imaging (mpMRI), and hepatic stiffness with magnetic resonance elastography (MRE). Amino acids and acylcarnitines were measured with mass spectrometry. Statistical analyses included paired Student's t-test, Wilcoxon-signed rank test, and Pearson's correlation.</p><p><strong>Results: </strong>Eight participants provided complete data. At baseline, all had hepatic steatosis (BMI 39.3 ± 5.6 kg/m<sup>2</sup>, PDFF ≥5%). Post-surgery reductions in PDFF (from 12.4 ± 6.7% to 6.2 ± 2.8%, <i>p</i> = 0.013) and cT1 (from 823.3 ± 85.4 ms to 757.5 ± 41.6 ms, <i>p</i> = 0.039) were significant, along with the GSG index (from 0.272 ± 0.03 to 0.157 ± 0.05, <i>p</i> = 0.001).</p><p><strong>Conclusion: </strong>The GSG index can potentially be developed as a marker for monitoring the response of patients with NAFLD to bariatric surgery.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 2","pages":"54-60"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Various Insulin Resistance Surrogate Indices in Thai People with Type 2 Diabetes Mellitus.
IF 0.6
Journal of the ASEAN Federation of Endocrine Societies Pub Date : 2024-01-01 Epub Date: 2024-09-13 DOI: 10.15605/jafes.039.02.21
Waralee Chatchomchuan, Yotsapon Thewjitcharoen, Soontaree Nakasatien, Ekgaluck Wanothayaroj, Sirinate Krittiyawong, Thep Himathongkam
{"title":"Assessment of Various Insulin Resistance Surrogate Indices in Thai People with Type 2 Diabetes Mellitus.","authors":"Waralee Chatchomchuan, Yotsapon Thewjitcharoen, Soontaree Nakasatien, Ekgaluck Wanothayaroj, Sirinate Krittiyawong, Thep Himathongkam","doi":"10.15605/jafes.039.02.21","DOIUrl":"https://doi.org/10.15605/jafes.039.02.21","url":null,"abstract":"<p><strong>Objective: </strong>To compare insulin surrogate indices with the homeostasis model assessment of insulin resistance (HOMA-IR) in Thai people with type 2 diabetes (T2D).</p><p><strong>Methodology: </strong>A cross-sectional study of 97 individuals with T2D was done to determine the association between HOMAIR and seven surrogate indices for insulin resistance. IR was defined as HOMA-IR ≥2.0. The indices included Waist Circumference (WC), Waist-to-Hip Ratio (WHR), Waist-to-Height Ratio (WHtR), Triglyceride-Glucose (TyG) index, estimated Glucose Disposal Rate (eGDR) calculated by WC, BMI, and WHR.</p><p><strong>Results: </strong>A total of 97 subjects with T2D (36.1% female, mean age 61.7 ± 12.0 years, BMI 26.4 ± 3.7 kg/m<sup>2</sup>, A1C 6.9 ± 1.2%) were studied. The TyG index showed a positive association with HOMA-IR, while eGDR exhibited a negative association. TyG index had the strongest correlation with IR (r = 0.49), while various eGDR formulas showed weaker negative correlations (r = 0.12-0.25). However, subgroup analysis in individuals with T2D and coronary artery disease (CAD) showed that only eGDR-WC and eGDR-BMI demonstrated a significant correlation with triple vessel disease.</p><p><strong>Conclusion: </strong>The TyG index was a useful and simple marker for identifying the presence of IR in Thai people with T2D. Future longitudinal studies are warranted to demonstrate the prediction value of cardiovascular outcomes.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 2","pages":"33-40"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604358/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Generative Artificial Intelligence (AI) in Scientific Publications. 科学出版物中的生成人工智能 (AI)。
IF 0.7
Journal of the ASEAN Federation of Endocrine Societies Pub Date : 2024-01-01 Epub Date: 2024-05-25 DOI: 10.15605/jafes.039.01.01
Elizabeth Paz-Pacheco
{"title":"Generative Artificial Intelligence (AI) in Scientific Publications.","authors":"Elizabeth Paz-Pacheco","doi":"10.15605/jafes.039.01.01","DOIUrl":"10.15605/jafes.039.01.01","url":null,"abstract":"","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 1","pages":"4-5"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Roles of Non-Pharmacologic and Emerging Pharmacologic Management of Non-alcoholic Fatty Liver Disease and Sarcopenia: A Narrative Review. 非药物疗法和新兴药物疗法在治疗非酒精性脂肪肝和 "肌肉疏松症 "中的作用:叙述性综述。
IF 0.7
Journal of the ASEAN Federation of Endocrine Societies Pub Date : 2024-01-01 Epub Date: 2023-10-27 DOI: 10.15605/jafes.039.01.04
Frederick Berro Rivera, Arcel Adizas, Deanna Cubarrubias, Nathan Ross Bantayan, Sarang Choi, Genquen Philip Carado, Marc Gregory Yu, Edgar Lerma, Krishnaswami Vijayaraghavan
{"title":"The Roles of Non-Pharmacologic and Emerging Pharmacologic Management of Non-alcoholic Fatty Liver Disease and Sarcopenia: A Narrative Review.","authors":"Frederick Berro Rivera, Arcel Adizas, Deanna Cubarrubias, Nathan Ross Bantayan, Sarang Choi, Genquen Philip Carado, Marc Gregory Yu, Edgar Lerma, Krishnaswami Vijayaraghavan","doi":"10.15605/jafes.039.01.04","DOIUrl":"10.15605/jafes.039.01.04","url":null,"abstract":"<p><p>Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent causes of chronic liver disease worldwide which is often seen in patients with metabolic abnormalities such as those with obesity and insulin resistance. On the other hand, sarcopenia is a generalized and progressive skeletal muscle disorder characterized by low muscle strength, low muscle quality, low physical performance, or a combination of the three. Both disease entities share several underlying risk factors and pathophysiologic mechanisms. These include: (1) cardiometabolic overlaps such as insulin resistance, chronic systemic inflammation, decreased vitamin D levels, sex hormone modifications; (2) muscle-related factors such as those mitigated by myostatin signaling, and myokines (i.e., irisin); and (3) liver-dysfunction related factors such as those associated with growth hormone/insulin-like growth factor 1 Axis, hepatokines (i.e., selenoprotein P and leukocyte cell-derived chemotaxin-2), fibroblast growth factors 21 and 19 (FGF21 and FGF19), and hyperammonemia. This narrative review will examine the pathophysiologic overlaps that can explain the links between NAFLD and sarcopenia. Furthermore, this review will explore the emerging roles of nonpharmacologic (e.g., weight reduction, diet, alcohol, and smoking cessation, and physical activity) and pharmacologic management (e.g., roles of β-hydroxy-β-methylbutyrate, branched-chain amino acid supplements, and testosterone therapy) to improve care, intervention sustainability, and acceptability for patients with sarcopenia-associated NAFLD.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 1","pages":"84-94"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Systematic Review of the Accuracy of Insulin and C-peptide Secretion Ratios During the Oral Glucose Tolerance Test to Diagnose Insulinoma. 关于口服葡萄糖耐量试验中胰岛素和 C 肽分泌比率诊断胰岛素瘤准确性的系统性综述。
IF 0.7
Journal of the ASEAN Federation of Endocrine Societies Pub Date : 2024-01-01 Epub Date: 2024-02-05 DOI: 10.15605/jafes.039.01.16
Fransiskus Mikael Chandra, Dicky Tahapary
{"title":"A Systematic Review of the Accuracy of Insulin and C-peptide Secretion Ratios During the Oral Glucose Tolerance Test to Diagnose Insulinoma.","authors":"Fransiskus Mikael Chandra, Dicky Tahapary","doi":"10.15605/jafes.039.01.16","DOIUrl":"10.15605/jafes.039.01.16","url":null,"abstract":"<p><strong>Background: </strong>Insulinoma is one of the causes of recurrent hypoglycemia, one of the chief complaints for emergency department admission. The gold standard in diagnosing insulinoma is a 72-hour fasting test which is inconvenient and inefficient as it requires hospitalization. Research has found that measurement of insulin and C-peptide during OGTT may help diagnose insulinoma. We aimed to assess the diagnostic value of OGTT in diagnosing insulinoma.</p><p><strong>Methodology: </strong>The literature search was conducted on 19 August 2022 using several databases (MEDLINE, Scopus, Embase, and ScienceDirect). All studies that measured OGTT as diagnostic tools in diagnosing insulinoma and 72-hour fasting test as reference standard were included. The quality assessment of the selected studies was based on the Centre of Evidence-Based Medicine University of Oxford and the Quality Assessment of Diagnostic Accuracy-2 tool (QUADAS-2). Analysis of the included studies was performed qualitatively. This study was registered on PROSPERO (CRD42022360205).</p><p><strong>Results: </strong>A total of two case-control studies (106 patients) were included, which were at risk of bias and low concern of applicability. Both studies demonstrated that the combination of insulin and C-peptide levels measured during OGTT had high specificity, sensitivity, positive predictive value, and negative predictive value in diagnosing insulinoma compared to the reference standard. A logistic regression model of 8.305 - (0.441 × insulin 2-h/0-h) - (1.679 × C-peptide 1-h/0-h) >0.351 has the highest diagnostic value in one study (AUC 0.97, Sensitivity 86.5%, Specificity 95.2%, PPV 94.1, NPV 88.9).</p><p><strong>Conclusion: </strong>The measurement of 0-h and 2-h insulin and C-peptide levels during 2-h OGTT was found in two small case-control studies with a total of 106 patients to have good sensitivity and specificity. However, due to these limitations, future research is still needed to validate the potential use of OGTT for the diagnosis of insulinoma.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 1","pages":"79-83"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163310/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信